eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
1/2025
vol. 20
 
Poleć ten artykuł:
Udostępnij:
List do Redakcji

Multimodal treatment for long-term survival in ampullary adenocarcinoma metastatic to the liver

Jakub Ciesielka
1
,
Karolina Majewska
2
,
Beata Jabłońska
2
,
Małgorzata Domagała-Haduch
3
,
Łukasz Liszka
4
,
Iwona Gisterek-Grocholska
3
,
Sławomir Mrowiec
2

  1. Students’ Scientific Association, Department of Digestive Tract Surgery, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  2. Department of Digestive Tract Surgery, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  3. Department of Oncology and Radiotherapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  4. Department of Pathomorphology and Molecular Diagnostics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
Gastroenterology Rev 2025; 20 (1): 102–106
Data publikacji online: 2025/03/16
Plik artykułu:
- Multimodal treatment.pdf  [1.47 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Rostain F, Hamza S, Drouillard A, et al. Trends in incidence and management of cancer of the ampulla of Vater. World J Gastroenterol 2014; 20: 10144-50.
2. Adam MA, Glencer A, AlMasri S, et al. Neoadjuvant therapy versus upfront resection for nonpancreatic periampullary adenocarcinoma. Ann Surg Oncol 2023; 30: 165-74.
3. Adnan A, Sheth RA, Tam A. Oligometastatic disease in the liver: the role of interventional oncology. Br J Radiol 2022; 95: 20211350.
4. Quero G, Laterza V, Fiorillo C, et al. The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation. Langenbecks Arch Surg 2022; 407: 2811-21.
5. Masiak-Segit W, Rawicz-Pruszyński K, Skórzewska M, et al. Surgical treatment of pancreatic cancer. Pol Przegl Chir 2018; 90: 45-53.
6. Sho M, Yasuda S, Nagai M, et al. Impact of surgery on oligometastatic pancreatic cancer: current status and future perspectives. J Dig Cancer Rep 2023; 11: 1-8.
7. de Jong MC, Tsai S, Cameron JL, et al. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 2010; 102: 256-63.
8. Takeda T, Sasaki T, Okamoto T, et al. Outcomes of pancreatic cancer with liver oligometastasis. J Hepatobiliary Pancreat Sci 2023; 30: 229-39.
9. Kim SM, Eads JR. Adjuvant and neoadjuvant therapy for resectable pancreatic and periampullary cancer. Surg Clin North Am 2016; 96: 1287-300.
10. Cloyd JM, Wang H, Overman M, et al. Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of vater. Ann Surg Oncol 2017; 24: 2031-9.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
© 2025 Termedia Sp. z o.o.
Developed by Bentus.